MedPath

Oxazepam

Oxazepam Capsules, USP CIV

Approved
Approval ID

03440821-831c-4085-98f9-faa88e98c503

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 2, 2023

Manufacturers
FDA

American Health Packaging

DUNS: 929561009

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Oxazepam

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62584-812
Application NumberANDA072253
Product Classification
M
Marketing Category
C73584
G
Generic Name
Oxazepam
Product Specifications
Route of AdministrationORAL
Effective DateDecember 2, 2023
FDA Product Classification

INGREDIENTS (13)

CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
D&C RED NO. 28Inactive
Code: 767IP0Y5NH
Classification: IACT
OXAZEPAMActive
Quantity: 10 mg in 1 1
Code: 6GOW6DWN2A
Classification: ACTIB
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

Oxazepam

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62584-813
Application NumberANDA072253
Product Classification
M
Marketing Category
C73584
G
Generic Name
Oxazepam
Product Specifications
Route of AdministrationORAL
Effective DateDecember 2, 2023
FDA Product Classification

INGREDIENTS (13)

CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
OXAZEPAMActive
Quantity: 15 mg in 1 1
Code: 6GOW6DWN2A
Classification: ACTIB

Oxazepam

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62584-814
Application NumberANDA072253
Product Classification
M
Marketing Category
C73584
G
Generic Name
Oxazepam
Product Specifications
Route of AdministrationORAL
Effective DateDecember 2, 2023
FDA Product Classification

INGREDIENTS (14)

CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
METHYLPARABENInactive
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Code: Z8IX2SC1OH
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
OXAZEPAMActive
Quantity: 30 mg in 1 1
Code: 6GOW6DWN2A
Classification: ACTIB
D&C RED NO. 28Inactive
Code: 767IP0Y5NH
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Oxazepam - FDA Drug Approval Details